Cargando…

Epigenetic Heterogeneity in Friedreich Ataxia Underlies Variable FXN Reactivation

Friedreich ataxia (FRDA) is typically caused by homozygosity for an expanded GAA triplet-repeat in intron 1 of the FXN gene. The expanded repeat induces repressive histone changes and DNA hypermethylation, which result in epigenetic silencing and FXN transcriptional deficiency. A class I histone dea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodden, Layne N., Gilliam, Kaitlyn M., Lam, Christina, Lynch, David R., Bidichandani, Sanjay I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655727/ https://www.ncbi.nlm.nih.gov/pubmed/34899161 http://dx.doi.org/10.3389/fnins.2021.752921

Ejemplares similares

FXN gene methylation determines carrier status in Friedreich ataxia
por: Lam, Christina, et al.
Publicado: (2023)

Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia
por: Rodden, Layne N, et al.
Publicado: (2021)

FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia
por: Chutake, Yogesh K., et al.
Publicado: (2015)

DNA methylation in Friedreich ataxia silences expression of frataxin isoform E
por: Rodden, Layne N., et al.
Publicado: (2022)

Identification of a novel missense mutation in Friedreich's ataxia –FXN(W) (168R)
por: Clark, Elisia, et al.
Publicado: (2019)

Clinical Evidence for Variegated Silencing in Patients With Friedreich Ataxia
por: Rodden, Layne N., et al.
Publicado: (2022)

Reversal of epigenetic promoter silencing in Friedreich ataxia by a class I histone deacetylase inhibitor
por: Chutake, Yogesh K., et al.
Publicado: (2016)

Hyperexpansion of GAA repeats affects post-initiation steps of FXN transcription in Friedreich’s ataxia
por: Kim, Eunah, et al.
Publicado: (2011)

SARS-CoV-2 in patients with Friedreich ataxia
por: Shen, Megan M., et al.
Publicado: (2022)

Pharmacological Screening Using an FXN-EGFP Cellular Genomic Reporter Assay for the Therapy of Friedreich Ataxia
por: Li, Lingli, et al.
Publicado: (2013)

Rescue of the Friedreich Ataxia Knockout Mutation in Transgenic Mice Containing an FXN-EGFP Genomic Reporter
por: Sarsero, Joseph P., et al.
Publicado: (2014)

Frataxin‐deficient neurons and mice models of Friedreich ataxia are improved by TAT‐MTScs‐FXN treatment
por: Britti, Elena, et al.
Publicado: (2017)

A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich’s Ataxia Patients
por: Misiorek, Julia O., et al.
Publicado: (2020)

Altered Nucleosome Positioning at the Transcription Start Site and Deficient Transcriptional Initiation in Friedreich Ataxia
por: Chutake, Yogesh K., et al.
Publicado: (2014)

Epigenetic Silencing in Friedreich Ataxia Is Associated with Depletion of CTCF (CCCTC-Binding Factor) and Antisense Transcription
por: De Biase, Irene, et al.
Publicado: (2009)

Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia
por: Mercado-Ayón, Elizabeth, et al.
Publicado: (2022)

Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia
por: Rodden, Layne N., et al.
Publicado: (2023)

Friedreich Ataxia Patient Tissues Exhibit Increased 5-Hydroxymethylcytosine Modification and Decreased CTCF Binding at the FXN Locus
por: Al-Mahdawi, Sahar, et al.
Publicado: (2013)

Interruptions of the FXN GAA Repeat Tract Delay the Age at Onset of Friedreich’s Ataxia in a Location Dependent Manner
por: Nethisinghe, Suran, et al.
Publicado: (2021)

Genetic Variations Creating MicroRNA Target Sites in the FXN 3′-UTR Affect Frataxin Expression in Friedreich Ataxia
por: Bandiera, Simonetta, et al.
Publicado: (2013)

Is Friedreich ataxia an epigenetic disorder?
por: Kumari, Daman, et al.
Publicado: (2012)

Epigenetic-based therapies for Friedreich ataxia
por: Sandi, Chiranjeevi, et al.
Publicado: (2014)

Novel intragenic deletion within the FXN gene in a patient with typical phenotype of Friedreich ataxia: may be more prevalent than we think?
por: Aguilera, Cinthia, et al.
Publicado: (2023)

Epigenetics in Friedreich's Ataxia: Challenges and Opportunities for Therapy
por: Sandi, Chiranjeevi, et al.
Publicado: (2013)

Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893)

Auditory Phenotypic Variability in Friedreich’s Ataxia Patients
por: Koohi, Nehzat, et al.
Publicado: (2021)

Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations
por: Medina-Carbonero, Marta, et al.
Publicado: (2022)

Predictors of loss of ambulation in Friedreich's ataxia
por: Rummey, Christian, et al.
Publicado: (2020)

Friedreich Ataxia: Multidisciplinary Clinical Care
por: Lynch, David R, et al.
Publicado: (2021)

Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort
por: Rummey, Christian, et al.
Publicado: (2021)

The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905)

Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)

Consensus clinical management guidelines for Friedreich ataxia
por: Corben, Louise A, et al.
Publicado: (2014)

FAST-1 antisense RNA epigenetically alters FXN expression
por: Mikaeili, Hajar, et al.
Publicado: (2018)

Analysis of Putative Epigenetic Regulatory Elements in the FXN Genomic Locus
por: Fernández-Frías, Iván, et al.
Publicado: (2020)

A non-synonymous single nucleotide polymorphism in SIRT6 predicts neurological severity in Friedreich ataxia
por: Rodden, Layne N., et al.
Publicado: (2022)

The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
por: Koeppen, Arnulf H., et al.
Publicado: (2015)

Depressive symptoms in Friedreich ataxia
por: Nieto, Antonieta, et al.
Publicado: (2018)

Heart disease in Friedreich’s ataxia
por: Hanson, Emily, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ra4qa8157i7j1v4mkegvr8aju